Abel Ureta-Vidal, Founder and CEO of Eagle Genomics, discusses how advanced DNA techniques help us to identify and characterise the microbiome, leading us to ways to prove cosmetic claims at the in-cosmetics formulation summit, 25th October 2017.
Digital transformation of translational medicineEagle Genomics
Anthony Finbow, Executive Chairman, and William Spooner, Chief Science Officer, discuss Eagle Genomics' software product, marketed at pharmaceutical and biotech companies, which enables radical improvements in the productivity of scientific research.
Expert Panel on Data Challenges in Translational ResearchEagle Genomics
A panel of experts including Alexandre Passioukov, VP Translational Medicine at Pierre Fabre, Xose Fernandez, Chief Data Officer at Institut Curie, Abel Ureta-Vidal, CEO at Eagle Genomics share their first-hand experience of enabling translational research in pharmaceutical and biomedical organisations, and discuss the challenges around the establishment of streamlined, seamless data handling and governance to accelerate innovation.
Considerations and challenges in building an end to-end microbiome workflowEagle Genomics
Many of the data management and analysis challenges in microbiome research are shared with genomics and other life-science big-data disciplines. However there are aspects that are specific: some are intrinsic to microbiome data, some are related to the maturity of the field, with others related to extracting business value from the data.
Dr. Dennis Wang discusses possible ways to enable ML methods to be more powerful for discovery and to reduce ambiguity within translational medicine, allowing data-informed decision-making to deliver the next generation of diagnostics and therapeutics to patients quicker, at lowered costs, and at scale.
The talk by Dr. Dennis Wang was followed by a panel discussion with Mr. Albert Wang, M. Eng., Head, IT Business Partner, Translational Research & Technologies, Bristol-Myers Squibb.
In the late Fall and Winter of 2018, the Pistoia Alliance in cooperation with Elsevier and charitable organizations Cures within Reach and Mission: Cure ran a datathon aiming to find drugs suitable for treatment of childhood chronic pancreatitis, a rare disease that causes extreme suffering. The datathon resulted in identification of four candidate compounds in a short time frame of just under three months. In this webinar our speakers discuss the technologies that made this leap possible
Pine.Bio slide deck - Idea Village CAPITALx (New Orleans Entrepreneur Week 2017)Elia Brodsky
Pine.Bio is changing the clinical bioinformatics speace by applying it's unique biAssociation engine to identify meaningful links between omics and clinical data, empowering better decisions and providing more options to patients.
Digital transformation of translational medicineEagle Genomics
Anthony Finbow, Executive Chairman, and William Spooner, Chief Science Officer, discuss Eagle Genomics' software product, marketed at pharmaceutical and biotech companies, which enables radical improvements in the productivity of scientific research.
Expert Panel on Data Challenges in Translational ResearchEagle Genomics
A panel of experts including Alexandre Passioukov, VP Translational Medicine at Pierre Fabre, Xose Fernandez, Chief Data Officer at Institut Curie, Abel Ureta-Vidal, CEO at Eagle Genomics share their first-hand experience of enabling translational research in pharmaceutical and biomedical organisations, and discuss the challenges around the establishment of streamlined, seamless data handling and governance to accelerate innovation.
Considerations and challenges in building an end to-end microbiome workflowEagle Genomics
Many of the data management and analysis challenges in microbiome research are shared with genomics and other life-science big-data disciplines. However there are aspects that are specific: some are intrinsic to microbiome data, some are related to the maturity of the field, with others related to extracting business value from the data.
Dr. Dennis Wang discusses possible ways to enable ML methods to be more powerful for discovery and to reduce ambiguity within translational medicine, allowing data-informed decision-making to deliver the next generation of diagnostics and therapeutics to patients quicker, at lowered costs, and at scale.
The talk by Dr. Dennis Wang was followed by a panel discussion with Mr. Albert Wang, M. Eng., Head, IT Business Partner, Translational Research & Technologies, Bristol-Myers Squibb.
In the late Fall and Winter of 2018, the Pistoia Alliance in cooperation with Elsevier and charitable organizations Cures within Reach and Mission: Cure ran a datathon aiming to find drugs suitable for treatment of childhood chronic pancreatitis, a rare disease that causes extreme suffering. The datathon resulted in identification of four candidate compounds in a short time frame of just under three months. In this webinar our speakers discuss the technologies that made this leap possible
Pine.Bio slide deck - Idea Village CAPITALx (New Orleans Entrepreneur Week 2017)Elia Brodsky
Pine.Bio is changing the clinical bioinformatics speace by applying it's unique biAssociation engine to identify meaningful links between omics and clinical data, empowering better decisions and providing more options to patients.
Pine Biotech - a company that merges big -omics data analysis with clinical care and precision applications for Real World Evidence: research & development of new targets and therapeutics, stratified clinical trials, and development of biomarkers for early detection and companion diagnostics. We want to improve patient outcomes and provide tools for researchers and clinicians to have an impact on healthcare.
With the explosion of interest in both enhanced knowledge management and open science, the past few years have seen considerable discussion about making scientific data “FAIR” — findable, accessible, interoperable, and reusable. The problem is that most scientific datasets are not FAIR. When left to their own devices, scientists do an absolutely terrible job creating the metadata that describe the experimental datasets that make their way in online repositories. The lack of standardization makes it extremely difficult for other investigators to locate relevant datasets, to re-analyse them, and to integrate those datasets with other data. The Center for Expanded Data Annotation and Retrieval (CEDAR) has the goal of enhancing the authoring of experimental metadata to make online datasets more useful to the scientific community. The CEDAR work bench for metadata management will be presented in this webinar. CEDAR illustrates the importance of semantic technology to driving open science. It also demonstrates a means for simplifying access to scientific data sets and enhancing the reuse of the data to drive new discoveries.
The poster was made during a 2.5 day NSF sponsored workshop on August 5th – 7th on the University of Washington, Seattle campus, which brought together 100 graduate students from diverse domain sciences and engineering with Data Scientists from industry and academia to discuss and collaborate on Big Data / Data Science challenges. In addition to keynote presentations from high profile speakers, the participants presented posters covering their own research and worked collaboratively to begin to solve some of the Grand Challenge problems facing Data Enabled Science & Engineering disciplines.
This presentation was made by 10 graduate students, whose united them was high-dimensional biological data.
For more info, see http://depts.washington.edu/dswkshp/
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
Presentation Alliance of European Life Sciences Law Firms
(Julian Hitchcock and Sofie van der Meulen) on legal aspects of big data in pharma. Topics: privacy, IP, medical devices and IVD.
The OmicsLogic Genomics Program provides in-depth understanding of bioinformatics methods we will cover in the upcoming 2019 session: https://edu.t-bio.info/organizations/omicslogic-genomics-training-program/
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
With applied Genomics expertise, global co-location with Central Labs and solutions from biomarker discovery to CDx, our genomics solutions will help make your Precision Medicine drug development a reality.
Pine Biotech - a company that merges big -omics data analysis with clinical care and precision applications for Real World Evidence: research & development of new targets and therapeutics, stratified clinical trials, and development of biomarkers for early detection and companion diagnostics. We want to improve patient outcomes and provide tools for researchers and clinicians to have an impact on healthcare.
With the explosion of interest in both enhanced knowledge management and open science, the past few years have seen considerable discussion about making scientific data “FAIR” — findable, accessible, interoperable, and reusable. The problem is that most scientific datasets are not FAIR. When left to their own devices, scientists do an absolutely terrible job creating the metadata that describe the experimental datasets that make their way in online repositories. The lack of standardization makes it extremely difficult for other investigators to locate relevant datasets, to re-analyse them, and to integrate those datasets with other data. The Center for Expanded Data Annotation and Retrieval (CEDAR) has the goal of enhancing the authoring of experimental metadata to make online datasets more useful to the scientific community. The CEDAR work bench for metadata management will be presented in this webinar. CEDAR illustrates the importance of semantic technology to driving open science. It also demonstrates a means for simplifying access to scientific data sets and enhancing the reuse of the data to drive new discoveries.
The poster was made during a 2.5 day NSF sponsored workshop on August 5th – 7th on the University of Washington, Seattle campus, which brought together 100 graduate students from diverse domain sciences and engineering with Data Scientists from industry and academia to discuss and collaborate on Big Data / Data Science challenges. In addition to keynote presentations from high profile speakers, the participants presented posters covering their own research and worked collaboratively to begin to solve some of the Grand Challenge problems facing Data Enabled Science & Engineering disciplines.
This presentation was made by 10 graduate students, whose united them was high-dimensional biological data.
For more info, see http://depts.washington.edu/dswkshp/
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
Presentation Alliance of European Life Sciences Law Firms
(Julian Hitchcock and Sofie van der Meulen) on legal aspects of big data in pharma. Topics: privacy, IP, medical devices and IVD.
The OmicsLogic Genomics Program provides in-depth understanding of bioinformatics methods we will cover in the upcoming 2019 session: https://edu.t-bio.info/organizations/omicslogic-genomics-training-program/
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
With applied Genomics expertise, global co-location with Central Labs and solutions from biomarker discovery to CDx, our genomics solutions will help make your Precision Medicine drug development a reality.
Welcome to Day 2 of the Biotech fundamentals course, recap of day 1 learnings and overview of the day’s Agenda, covering:
• Medical devices and diagnostics
• Industrial applications and CleanTech
• Aquaculture
• Agriculture
The introductory slide deck is based on a Biotechnology Fundamentals course we delivered to AusIndustry (Australian Government, Department of Industry) R&D Tax Assessors in May/June 2014. It covers the broad concept of biotechnology from its historical relevance to its impact in the achievement of contemporary objectives in the fields of medicine, plant and animal sciences, in food, marine and environmental sciences, drawing comparisons with conventional technologies, introducing the concepts of bioethics, patenting and other regulatory issues and providing non-science professionals with a basic understanding of the science, technology, regulatory and commercial environments driving the biotechnology sectors, delivered in bite sized portions. The first deck is a Welcome and Overview covering:
• Definition of biotechnology
• Historical relevance
• Contemporary objectives with overview of industry sub-sectors
• State of play
Dr. Mark Allen - Present & Future: Bovine Genetic & Reproductive TechnologiesJohn Blue
Present & Future: Bovine Genetic & Reproductive Technologies - Dr. Mark Allan, Director Marketing and Genomics, Trans Ova Genetics, from the 2014 NIAA Annual Conference titled 'The Precautionary Principle: How Agriculture Will Thrive', March 31 - April 2, 2014, Omaha, NE, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2014_niaa_how_animal_agriculture_will_thrive
This presentation was given at a March 2013 meeting of the HEA STEM Special Interest Group on teaching ethics to bioscience students. The meeting was hosted at the University of Northampton, UK, and the principal focus was on teaching about Ethics and Risk.
Professor Joe Perry is a member of the European Food Safety Authority (EFSA).
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Validating microbiome claims – including the latest DNA techniques
1. Validating microbiome claims – including the
latest DNA techniques
Abel Ureta-Vidal
Founder & CEO of Eagle Genomics
abel.uretavidal@eaglegenomics.com
In-cosmetics® formulation summit, 25th October 2017
2. About Eagle Genomics
Based in Cambridge, UK since 2008, on the Wellcome Genome Campus
AI augmented knowledge discovery platform for Life Sciences
• Human & animal health
• Personal care and cosmeceuticals
• Food and nutraceuticals
Delivering the innovation platform for the genomics era
e[automateddatascientist]
• to enable data driven decisions
• to increase the success rate of innovation
12. Space – the final frontier
Effects of space travel on the human microbiome
http://journal.frontiersin.org/article/10.3389/fspas.2016.00023/full
13. Scaling up of microbiomics DNA analysis, the easy part!
The metagenomics pipeline runs in less than 24h for about $30
The platform can sustain10x increase in input across 100s of studies
Also can improve the precision of the analysis at the subspecies/strain level
Numberofsequencingreads
16S 454 16S Illumina
Metagenomics
Illumina
Human Genome
30x
Human exome
50x
1m
470m
1.7b
720m
60m
2011
Today
Cf. Human
14. Favouring a microbiome ecosystem for heathier mouth and gum
Past: Stand alone Present: Server/Cluster
Emerging: Secure
Scalable Cloud
Weeks / Months Days / Weeks Hours
100K Reads 5 Billion reads
17. Today: Significant inertia in biologists doing data-rich tasks
Data sources
meta data
summary
documents
protocols
experiment
al & clinical
reports
Concept entailment
process
concepts
entities relations
Jennifer
Biologist
18. We have generalised for many applications…
Genomics
profile
‘omics profile
Molecular
resultsGenes &
pathways
Safety
Toxicology
Consumer
Patient
Animal
Plant
Product
Indication
Disease
Health status
Quality trait
RWD
Market access
data
Microbiome
profile
Externally-exposed mucosa
Skin/scalp
Gut (human, animal)
Blood
Soil
Ocean/river/water
Food
19. …in many different sectors
Food & nutrition Skin biology
Biomedical
research
Animal health &
breeding
…
Soil engineering
& plant yield
Environment
20. The Automated Data Scientist
AI augmented knowledge discovery to enable data-driven innovation
22. The bottleneck to data-driven innovation and data
governance
insight
CURATE CATALOGUE DISCOVER EXPLOIT
big data
AI
Machine
Learning
Modelling
Focus of the industry for AI + ML applications
necessary but not sufficient
50
40
30
20
10
0
Curate Catalog Discover Exploit
effort
value
23. Accelerating data driven innovation
insight
CURATE CATALOGUE DISCOVER EXPLOIT
big data
Conversational Learning
Eagle Genomics focus – across the entire bridge
50
40
30
20
10
0
Curate Catalog Discover Exploit
INTEGRATE STORE EXPLORE ANALYZE
AI & Machine Learning
Measurement Framework
Effort distributed
Value captured earlier